Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

COVID infections, even if mild or asymptomatic, may be causing long-term cellular and organ damage, as well as increasing ...

Scientists have learned more about how SARS-CoV-2 infections, which cause COVID-19, can ruin the ability of immune cells to ...

Concurrent analysis of whole-genome DNA methylation and single-cell RNA sequencing data from COVID-19 patients and controls ...

SARS-CoV-2, the virus responsible for COVID-19 ... In vitro experiments with human lung-derived Calu-3 cells showed clear ...

Several studies have suggested that COVID-19 may increase a person’s risk of developing cancer or promote metastasis of existing cancer.

Here the authors characterise the cellular and molecular progression of lung alveolar damage in severe ... COVID-19 increases with age upon SARS-CoV-2 infection and even milder disease ...

The Covid-19 pandemic reveals itself not as a singular event but as a multifaceted crisis that exposed deep-seated fault ...

Changes in the cellular response during lung damage caused by SARS-CoV-2 – the virus behind COVID-19 – have been uncovered. Researchers reveal distinct phases where waves of immune responses give way ...

Research identifies how viral respiratory infection damages macrophages and suggests treatment with a pre-existing FDA approved drug.

Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...

The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines helped control the spread of the virus, the emergence of new variants ...